Considering the utility and safety of GLP-1RAs as existing anti-diabetic remedies (Gilbert et al., 2020) and the advancement of clinical trials of Ex-4 toward PD (Vijiaratnam et al., 2021), it does not seem exaggerated to describe them as promising agents for myelin regeneration and repair
While more research is needed to fully understand the relationship between glutathione and COVID-19, preliminary studies suggest that optimizing glutathione levels could potentially play a role in mitigating the severity of the disease
High doses of exogenous glucagon stimulate insulin secretion and reduce insulin clearance in healthy humans
The nutraceuticals discussed in the present paper have antioxidative properties and are increasingly used by migraine patients not only due to mild or even a lack of side effects but also because of their effectiveness (decreased frequency of migraine episodes or shortening of an episode duration)
Compared to the placebo group, those who received the silymarin saw a "significant decrease" in their levels of key diabetic markers hemoglobin A1C, fasting blood sugar, total cholesterol, low-density lipoprotein ("bad") cholesterol, and triglycerides.17 The second is a recent review published in the Annals of Hepatology in 2021, much of which relates to silymarin's effect on insulin resistance,18 a prominent marker for type 2 diabetes.19 Two of the studies referenced in the review were animal studies that administered 26.25-100mg/kg of silybin to rat subjects (equivalent to around 366-1,395mg for an 86kg, or 190lb, human) across 6-12 weeks